Evaluation of the effects of synbiotic supplementation on weight gain, fecal ph, acetate, lactate, calprotectin in preterm infants
Not Applicable
- Conditions
- Preterm infants.Digestive system disorders of fetus and newborn
- Registration Number
- IRCT2016061128386N1
- Lead Sponsor
- Vice chancellor for research, Alborz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 160
Inclusion Criteria
Infants weighing less than 2500 g or 37 week; all premature infants hospitalized in Kamali Hospital of Karaj
Exclusion criteria: in the case of clinical symptoms of Sepsis (including severe lethargy, inability to feed, frequent vomiting, impaired consciousness, seizures, severe abdominal distention, laboratory findings such as positive blood culture and elevated CRP); critically ill patient for any reason.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Body Weight. Timepoint: 14 days. Method of measurement: weightening for body weight.;Fecal lactate. Timepoint: 14 days. Method of measurement: GC-MASS.;Fecal calprotectin. Timepoint: 14 days. Method of measurement: ELISA kit.;Fecal acetate. Timepoint: 14 days. Method of measurement: GC-MASS.
- Secondary Outcome Measures
Name Time Method Duration of hospitalization in. Timepoint: day of discharge from hospital. Method of measurement: Counting days.